Search by Drug Name or NDC

    NDC 00555-0483-02 Amiloride Hydrochloride and Hydrochlorothiazide 5; 50 mg/1; mg/1 Details

    Amiloride Hydrochloride and Hydrochlorothiazide 5; 50 mg/1; mg/1

    Amiloride Hydrochloride and Hydrochlorothiazide is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Pharmaceuticals USA, Inc.. The primary component is AMILORIDE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE.

    Product Information

    NDC 00555-0483
    Product ID 0555-0483_3c6d3a11-6d0b-4109-89cd-658827847fea
    Associated GPIs 37990002100310
    GCN Sequence Number 008178
    GCN Sequence Number Description amiloride/hydrochlorothiazide TABLET 5 MG-50 MG ORAL
    HIC3 R1L
    HIC3 Description POTASSIUM SPARING DIURETICS IN COMBINATION
    GCN 82341
    HICL Sequence Number 003648
    HICL Sequence Number Description AMILORIDE HCL/HYDROCHLOROTHIAZIDE
    Brand/Generic Generic
    Proprietary Name Amiloride Hydrochloride and Hydrochlorothiazide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Amiloride Hydrochloride and Hydrochlorothiazide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 5; 50
    Active Ingredient Units mg/1; mg/1
    Substance Name AMILORIDE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE
    Labeler Name Teva Pharmaceuticals USA, Inc.
    Pharmaceutical Class Decreased Renal K+ Excretion [PE], Increased Diuresis [PE], Increased Diuresis [PE], Potassium-sparing Diuretic [EPC], Thiazide Diuretic [EPC], Thiazides [CS]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA071111
    Listing Certified Through 2024-12-31

    Package

    NDC 00555-0483-02 (00555048302)

    NDC Package Code 0555-0483-02
    Billing NDC 00555048302
    Package 100 TABLET in 1 BOTTLE (0555-0483-02)
    Marketing Start Date 1989-12-01
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 0.4532
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description AMILORIDE HCL-HYDROCHLOROTHIAZIDE 5-50 MG TAB
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis